MicroPort Scientific Corp - Stock Quote MCRPF
Morningstar's MicroPort Scientific Corp Stock Analysis
1-Star Price
PREMIUM
5-Star Price
PREMIUM
Economic Moat
PREMIUM
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible for overseeing the methodology that supports the quantitative fair value. As an employee of Morningstar, Inc., Mr. Davidson is guided by Morningstar, Inc.'s Code of Ethics and Personal Securities Trading Policy in carrying out his responsibilities. For information regarding Conflicts of Interests, click here .
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
MicroPort Scientific Corp's Company Profile
MicroPort Scientific Corp develops, makes, and markets medical devices in four major segments: orthopedics, cardiovascular, cardiac rhythm management, and others. The orthopedics business sells reconstructive joints, spine, trauma, and sports medicine products, and other implants and equipment. The cardiovascular devices business sells products for the treatment of coronary artery disease. The CRM business develops and manufactures defibrillators, cardiac therapy devices, and pacemakers. The other business sells endovascular, electrophysiological, neurovascular, and surgical devices. MicroPort Scientific generates the largest proportion of its revenue in China.
Shanghai, 201203, China, People's Republic of